SCHEMBL684844

SCHEMBL684844

O=C(N/N=C/c1cc(Cl)ccc1O)c1ccccc1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 6/20 0.80
MEN1 O00255 5/20 0.76
KMT2A Q03164 5/20 0.76
KDM4E B2RXH2 4/20 0.76
RAB9A P51151 4/20 0.76
HTT P42858 4/20 0.76
NPC1 O15118 3/20 0.76
LMNA P02545 2/20 0.76
SMN1; SMN2 Q16637 2/20 0.76
MITF O75030 2/20 0.76
L3MBTL1 Q9Y468 2/20 0.76
PSMD14 O00487 1/20 0.76
POLB P06746 1/20 0.76
MMP2 P08253 1/20 0.76
BLM P54132 1/20 0.76
GPR174 Q9BXC1 1/20 0.76
KLF5 Q13887 1/20 0.73
MAPT P10636 1/20 0.69
ATM Q13315 1/20 0.65
PIK3CG P48736 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6568344 0.92 KDM1A (0.89) KDM1AMEN1KMT2AKDM4ERAB9A
SCHEMBL683818 0.92 KDM1A (0.89) KDM1AMEN1KMT2AKDM4ERAB9A
SCHEMBL6568342 0.92 KDM1A (0.89) KDM1AMEN1KMT2AKDM4ERAB9A
SCHEMBL684639 0.90 KDM1A (0.81) KDM1AMEN1KMT2AKDM4ERAB9A
SCHEMBL6751419 0.90 KDM1A (0.81) KDM1AMEN1KMT2AKDM4ERAB9A
SCHEMBL6751416 0.90 KDM1A (0.81) KDM1AMEN1KMT2AKDM4ERAB9A
SCHEMBL14285643 0.89 KDM1A (1.00) KDM1AMEN1KMT2AKDM4ERAB9A
SCHEMBL684659 0.89 KDM1A (0.70) KDM1AMEN1KMT2AKDM4ERAB9A
SCHEMBL19283330 0.89 KDM1A (1.00) KDM1AMEN1KMT2AKDM4ERAB9A
SCHEMBL684783 0.88 KDM1A (0.82) KDM1AMEN1KMT2AKDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180072675-A1 ANTIMICROBIAL PYRIDINOHYDRAZIDE AND HYDRAZOMETHYLPYRIDINE-BASED AGENTS BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE 2018-03-15 US disclosed
US-8906829-B2 Synergistic algicidal compositions including hydrazone derivatives and copper DOW AGROSCIENCES LLC (US) 2014-12-09 US disclosed
US-8906829-B2 Synergistic algicidal compositions including hydrazone derivatives and copper DOW AGROSCIENCES LLC (US) 2014-12-09 US disclosed
US-20120046170-A1 SYNERGISTIC ALGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER DOW AGROSCIENCES LLC (US) 2012-02-23 US disclosed
US-20120046170-A1 SYNERGISTIC ALGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER DOW AGROSCIENCES LLC (US) 2012-02-23 US disclosed
WO-2012024494-A1 SYNERGISTIC ALGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER DOW AGROSCIENCES LLC (US) 2012-02-23 WO disclosed
US-20120010075-A1 SYNERGISTIC FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER DOW AGROSCIENCES LLC (US) 2012-01-12 US disclosed
US-20120010075-A1 SYNERGISTIC FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER DOW AGROSCIENCES LLC (US) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010075-A1 SYNERGISTIC FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER SOD1, CYP51A1, SOD3 KDM1A 484/4885MEN1 536/4885KMT2A 1362/4885
US-20120046170-A1 SYNERGISTIC ALGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER ALG1, SOD1, DHPS KDM1A 3346/4885MEN1 3435/4885KMT2A 2866/4885
US-20180072675-A1 ANTIMICROBIAL PYRIDINOHYDRAZIDE AND HYDRAZOMETHYLPYRIDINE-BASED AGENTS CLPP, HPD, PDXK KDM1A 1666/4885MEN1 2233/4885KMT2A 3102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.